California Public Employees Retirement System Sage Therapeutics, Inc. Transaction History

California Public Employees Retirement System

$152 Billion
Q2 2025

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$30.71 - $45.71 $3.68 Million - $5.47 Million	-119,702 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$40.26 - $57.37 $124,041 - $176,756	-3,081 Reduced 2.51%	119,702 $5.3 Million
Q2 2021 Aug 13, 2021	SELL	$54.88 - $79.29 $260,625 - $376,548	-4,749 Reduced 3.72%	122,783 $6.98 Million
Q1 2021 May 14, 2021	SELL	$70.65 - $96.76 $168,570 - $230,869	-2,386 Reduced 1.84%	127,532 $9.55 Million
Q4 2020 Feb 02, 2021	BUY	$58.41 - $89.06 $1.32 Million - $2.01 Million	22,618 Added 21.08%	129,918 $11.2 Million
Q3 2020 Nov 05, 2020	BUY	$41.13 - $62.45 $127,503 - $193,595	3,100 Added 2.98%	107,300 $6.56 Million
Q2 2020 Aug 12, 2020	SELL	$25.95 - $43.15 $12,975 - $21,575	-500 Reduced 0.48%	104,200 $4.33 Million
Q1 2020 May 12, 2020	SELL	$26.15 - $77.24 $198,844 - $587,332	-7,604 Reduced 6.77%	104,700 $3.01 Million
Q4 2019 Jan 27, 2020	BUY	$60.18 - $154.77 $1.11 Million - $2.87 Million	18,516 Added 19.74%	112,304 $8.11 Million
Q3 2019 Oct 31, 2019	BUY	$140.29 - $189.96 $4.71 Million - $6.38 Million	33,588 Added 55.79%	93,788 $13.2 Million
Q2 2019 Aug 15, 2019	SELL	$157.85 - $183.09 $220,990 - $256,326	-1,400 Reduced 2.27%	60,200 $11 Million
Q1 2019 May 03, 2019	SELL	$89.33 - $163.65 $89,330 - $163,650	-1,000 Reduced 1.6%	61,600 $9.8 Million
Q4 2018 Feb 08, 2019	BUY	$81.94 - $139.71 $168,386 - $287,104	2,055 Added 3.39%	62,600 $6 Million
Q3 2018 Nov 13, 2018	SELL	$138.11 - $169.04 $559,483 - $684,781	-4,051 Reduced 6.27%	60,545 $8.55 Million
Q2 2018 Aug 15, 2018	SELL	$140.36 - $175.76 $711,484 - $890,927	-5,069 Reduced 7.28%	64,596 $10.1 Million
Q1 2018 May 11, 2018	SELL	$152.15 - $192.33 $759,989 - $960,688	-4,995 Reduced 6.69%	69,665 $11.2 Million
Q4 2017 Feb 06, 2018	BUY	$60.72 - $167.34 $3.76 Million - $10.4 Million	61,961 Added 487.92%	74,660 $12.3 Million
Q3 2017 Nov 15, 2017	BUY	$61.4 - $88.52 $779,718 - $1.12 Million	12,699	12,699 $791,000

Others Institutions Holding SAGE

# of Institutions

221

Shares Held

49.6M

Call Options Held

241K

Put Options Held

587K

Black Rock Inc. New York, NY

5.22M
Shares

$45.3 Million
0.0% of portfolio
Madison Avenue Partners, LP New York, NY

4.48M
Shares

$38.9 Million
4.6% of portfolio
Vanguard Group Inc Valley Forge, PA

3.27M
Shares

$28.3 Million
0.0% of portfolio
Tig Advisors, LLC New York, NY

2.73M
Shares

$23.7 Million
1.36% of portfolio
D. E. Shaw & Co., Inc. New York, NY

2.09M
Shares

$18.1 Million
0.02% of portfolio

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $516M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account